gossypol has been researched along with antimycin a in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 2 (66.67) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (33.33) | 2.80 |
Authors | Studies |
---|---|
Dale, GL; Friese, P | 1 |
Tang, Y; Wu, XM; Zhang, DY | 1 |
Bränström, R; Chen, Z; Cui, HL; Gao, J; Huang, WK; Larsson, C; Li, S; Lui, WO; Shi, H; Yeh, CN; Yuan, J | 1 |
1 review(s) available for gossypol and antimycin a
Article | Year |
---|---|
[Progress in small-molecule inhibitors of Bcl-2 family proteins].
Topics: Antimycin A; Antineoplastic Agents; Apoptosis; bcl-X Protein; Benzopyrans; Biphenyl Compounds; Cell Line, Tumor; Drug Design; Drugs, Chinese Herbal; Gossypol; Humans; Nitriles; Nitrophenols; Piperazines; Proto-Oncogene Proteins c-bcl-2; Structure-Activity Relationship; Sulfonamides; Thiazoles; Thiazolidinediones | 2008 |
2 other study(ies) available for gossypol and antimycin a
Article | Year |
---|---|
Bax activators potentiate coated-platelet formation.
Topics: Antimycin A; Apoptosis; bcl-2-Associated X Protein; Blood Platelets; Cell Membrane; Crotalid Venoms; Dose-Response Relationship, Drug; Fibrinogen; Gossypol; Humans; In Vitro Techniques; Lectins, C-Type; Membrane Potential, Mitochondrial; Mitochondria; Peptide Fragments; Peptides; Phosphatidylserines; Platelet Activation; Proto-Oncogene Proteins; Secretory Vesicles; Thrombin | 2006 |
Heterogeneity of Metabolic Vulnerability in Imatinib -Resistant Gastrointestinal Stromal Tumor.
Topics: Antimycin A; Cell Death; Cell Line, Tumor; Cell Proliferation; Drug Resistance, Neoplasm; Energy Metabolism; Gastrointestinal Stromal Tumors; Gene Expression Regulation, Neoplastic; Glycolysis; Gossypol; Humans; Imatinib Mesylate; Oligomycins; Organelle Biogenesis; Oxidative Phosphorylation; Phenotype; Pyruvates | 2020 |